Global Animal Antibiotics and Antimicrobials Market

  • Report Code : VMI235897
  • Pages : 136
  • Published On : Dec 2018
  • Industry : Healthcare and Pharmaceuticals
  • Format :

Choose License Type

Single User License: US$ 3,950
Multi User License: US$ 4,750
Corporate User License: US$ 6,750
Market Overview:
The global Animal Antibiotics and Antimicrobialsmarket was valued at USD 3.76billion in 2016 and is projected to reach USD 5.60billionby 2025, growing at a CAGR of 4.54% from 2017 to 2025.
Animal Antibiotics are in high demand due to increasing breeding practices and increment in Animal Product requirement. The market is expected to grow during the forecast period at a high rate.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Rising Demand for Animal-Derived Food Products
1.2 Increasing Incidence of Zoonotic Diseases
1.3 Implementation of Regulations for Preventing the Spread of Animal Diseases
1.4 Rising Demand for Pet Insurance and Growing Animal Health Expenditure
2. Market Restraints
2.1 Dearth of New Antibiotics
2.2 Growing Resistance to Antimicrobials and Antibiotics
2.3 Routine Prophylactic Use of Antibiotics Being Replaced By Good Husbandry and Hygiene Practices

Market Segmentation:
1. By Mode Of Delivery:
1.1 Premixes
1.2 Oral Powders
1.3 Oral Solutions
1.4 Injections
1.5 Other Modes of Delivery

2. By Product:
2.1 Tetracyclines
2.2 Penicillins
2.3 Sulfonamides
2.4 Macrolides
2.5 Aminoglycosides
2.6 Lincosamides
2.7 Fluoroquinolones
2.8 Cephalosporins
2.9 Other Antimicrobials and Antibiotics

3. By Type of Animal:
3.1 Food Producing
3.1.1 Cattle
3.1.2 Pigs
3.1.3 Poultry
3.1.4 Sheep and Goats
3.1.5 Other Food-Producing Animals
3.2 Companion
3.2.1 Dogs
3.2.2 Cats
3.2.3 Horses
3.2.4 Other Companion Animals

4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Zoetis, Inc.
2. BoehringerIngelheim GmbH
3. Eli Lilly and Company
4. Merck & Co., Inc.
5. Bayer AG
6. Sanofi
7. CevaSanteAnimale
8. Virbac
9. Vetoquinol S.A.
10. Dechra Pharmaceuticals PLC
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Animal Antibiotics and Antimicrobialsmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALSMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET, BY MODE OF DELIVERY:
5.1 Overview
5.2 Premixes
5.3 Oral Powders
5.4 Oral Solutions
5.5 Injections
5.6 Other Modes of Delivery

6 GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET, BY PRODUCT:
6.1 Overview
6.2 Tetracyclines
6.3 Penicillins
6.4 Sulfonamides
6.5 Macrolides
6.6 Aminoglycosides
6.7 Lincosamides
6.8 Fluoroquinolones
6.9 Cephalosporins
6.10 Other Antimicrobials and Antibiotics

7 GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET, BY TYPE OF ANIMAL:
7.1 Overview
7.2 Food Producing
7.2.1 Cattle
7.2.2 Pigs
7.2.3 Poultry
7.2.4 Sheep and Goats
7.2.5 Other Food-Producing Animals
7.3 Companion
7.3.1 Dogs
7.3.2 Cats
7.3.3 Horses
7.3.4 Other Companion Animals

8 GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALSMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

9 GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALSMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Zoetis, Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 BoehringerIngelheim GmbH
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Eli Lilly and Company
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Merck & Co., Inc.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Bayer AG
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Sanofi
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 CevaSanteAnimale
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Virbac
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Vetoquinol S.A.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development

10.10 Dechra Pharmaceuticals PLC
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development

11 Appendix
11.1 Related Reports

Animal Video Tracking Software Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Animal Video Tracking Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...

Business Opportunities and Investment Strategies for Global Feed Antibiotics Market 2023-2033...

Opportunity and Strategy Analysis This report focuses on identifying opportunities and strategies for investing in the global feed antibiotics market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysi...

Global Animal Feed Additive Market 2024...

The application of additives in animal feeds serves to enhance their biological and physiological characteristics, while also playing a vital role in improving functions such as digestion, metabolism, and reproduction, as well as addressing deficiencies. The market for animal feed additives presents...

Animal Simulator Game Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Animal Simulator Game Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers...

Asia Pacific Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...

Europe Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing tech...

North America Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology s...

Global Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Region: Trend Forecast and Growth Opportunity...

Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technologic...

Global Animal Boarding Franchise Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Animal Boarding Franchise Market: The report discusses everything a marketer requires before investing in the global Animal Boarding Franchise Market during the forecast period 2023-2030. It p...

Global Animal Feed Quality Analysis Services Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Animal Feed Quality Analysis Services Market: The report discusses everything a marketer requires before investing in the global Animal Feed Quality Analysis Services Market during the forecas...